These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6276716)

  • 21. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inadequate superoxide production by canine neutrophils in response to the combination of N-formyl-methionyl-leucyl-phenylalanine and cytochalasin B.
    Ing TS; Yu AW; Patel M; Gupta V; Khan MA; Agrawal A; Patel P
    Am J Vet Res; 1994 Feb; 55(2):288-90. PubMed ID: 8172421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the synthetic inhibitor tosylamino-phenylethyl-chloromethylketone on chemotactic peptide receptor activation and superoxide production in human neutrophils.
    Suter S; Lew PD; Waldvogel FA
    Pediatr Res; 1986 Sep; 20(9):848-52. PubMed ID: 3018658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils.
    Bylund J; Pellmé S; Fu H; Mellqvist UH; Hellstrand K; Karlsson A; Dahlgren C
    BMC Cell Biol; 2004 May; 5():21. PubMed ID: 15157285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
    Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
    English D; Lukens JN
    J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cell surface contact in the kinetics of superoxide production by granulocytes.
    Dahinden CA; Fehr J; Hugli TE
    J Clin Invest; 1983 Jul; 72(1):113-21. PubMed ID: 6308042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of proteinase inhibitors on polymorphonuclear neutrophil polarization.
    Aoshiba K; Nagai A; Takizawa T
    Tohoku J Exp Med; 1991 Nov; 165(3):165-70. PubMed ID: 1807003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary defense mechanisms: modulation of Fc receptor activity in alveolar macrophages and other phagocytic cells by N-formyl peptides.
    Rossman MD; Cassizzi AM; Schreiber AD; Daniele RP
    Am Rev Respir Dis; 1982 Jul; 126(1):136-41. PubMed ID: 7201286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cytochalasin A on polymorphonuclear leukocytes activated by chemotactic peptide.
    Elferink JG; Riemersma JC
    J Reticuloendothel Soc; 1981 Feb; 29(2):163-71. PubMed ID: 6260942
    [No Abstract]   [Full Text] [Related]  

  • 32. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.
    Becker EL; Sigman M; Oliver JM
    Am J Pathol; 1979 Apr; 95(1):81-97. PubMed ID: 219701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of pepstatin A on neutrophils; cross-deactivation with FMLP].
    Muniain MA; Pozuelo F; Pérez-Venegas JJ; Romero-Tabares A; Rodríguez-Hornillo MC; Garrido M
    Rev Esp Fisiol; 1985 Mar; 41(1):125-31. PubMed ID: 2988085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of interleukin-1 as a complete secretagogue for human neutrophils.
    Smith RJ; Speziale SC; Bowman BJ
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1233-40. PubMed ID: 2992505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motility and adhesiveness in human neutrophils. Redistribution of chemotactic factor-induced adhesion sites.
    Smith CW; Hollers JC
    J Clin Invest; 1980 Apr; 65(4):804-12. PubMed ID: 7358846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemotactic factors induced movement of calcium and sodium across rabbit neutrophil membranes: effect of densensitization to cytochalasin B.
    Naccache PH; Showell HJ; Becker EL; Sha'afi RI
    J Cell Physiol; 1979 Aug; 100(2):239-50. PubMed ID: 511943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents.
    O'Flaherty JT; Wykle RL; Lees CJ; Shewmake T; McCall CE; Thomas MJ
    Am J Pathol; 1981 Dec; 105(3):264-9. PubMed ID: 6274199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
    Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
    Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.